R1 RCM is anticipating “minimal long-term impacts” from Medicaid redeterminations, CEO Lee Rivas told investors during the company’s Aug. 2 earnings call, according to a transcript from Seeking Alpha.
Read the full post on Becker's Hospital Review - Healthcare News
